CTOs on the Move

OnKure Therapeutics

www.onkuretherapeutics.com

 
OnKure, Inc. is a biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to improve the outcomes of patients afflicted with cancer. OnKure`s drug candidates aim to treat patients by targeting malignant cells directly, by working in combination with other small molecule therapies and by priming the tumor microenvironment such that checkpoint inhibition is optimized.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

OnKure Therapeutics raised $55M on 03/04/2021

Similar Companies

Dracen Pharmaceuticals

Dracen is a privately funded biotech company developing drugs in the area in of immuno metabolism.

ICON Clinical Research

ICON Clinical Research is a North Wales, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vesta

University Cancer & Blood Center

University Cancer & Blood Center’s highly skilled medical professionals, whose backgrounds include working at the nation’s leading cancer centers, provide every patient with the...

Brogan Pharmaceuticals

Brogan Pharmaceuticals is a Crown Point, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.